These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9570634)

  • 1. Adjuvant immunotherapy for patients with melanoma.
    Myers JN
    Head Neck; 1998 May; 20(3):270. PubMed ID: 9570634
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant immunotherapy for patients with melanoma: are patients with melanoma of the head and neck candidates for this therapy?
    Shaw PM; Sivanandham M; Bernik SF; Ditaranto K; Wallack MK
    Head Neck; 1997 Oct; 19(7):595-603. PubMed ID: 9323148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunotherapy with B.C.G. for recurrent malignant melanoma.
    Gutterman JU; Mavligit G; McBride C; Frei E; Freireich EJ; Hersh EM
    Lancet; 1973 Jun; 1(7814):1208-12. PubMed ID: 4122562
    [No Abstract]   [Full Text] [Related]  

  • 4. An update on the current management of head and neck mucosal melanoma.
    Green B; Elhamshary A; Gomez R; Rahimi S; Brennan PA
    J Oral Pathol Med; 2017 Aug; 46(7):475-479. PubMed ID: 27864904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Head and neck cancer : promising results of immunotherapy].
    Sivade A; Bensaid D; Monnier Y; Shabafrouz K; Bouchaab H; Cristina V
    Rev Med Suisse; 2017 May; 13(563):1029-1031. PubMed ID: 28636292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology evaluation: Allovectin-7, Vical.
    Galanis E
    Curr Opin Mol Ther; 2002 Feb; 4(1):80-7. PubMed ID: 11883699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Melanoma treatment--BCG as adjuvant.
    Stein RS
    N Engl J Med; 1976 Apr; 294(18):1011. PubMed ID: 1256503
    [No Abstract]   [Full Text] [Related]  

  • 8. Melanoma of the head and neck: current concepts in staging, diagnosis, and management.
    Younes MN; Myers JN
    Surg Oncol Clin N Am; 2004 Jan; 13(1):201-29. PubMed ID: 15062370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?
    Ferris RL
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):332-40. PubMed ID: 15668533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 16 cases of malignant head and neck melanoma].
    Ryuto M; Higaki Y; Tomita K
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Sep; 104(9):859-65. PubMed ID: 11605226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: mucosal melanoma of the head and neck.
    Gavriel H; McArthur G; Sizeland A; Henderson M
    Melanoma Res; 2011 Aug; 21(4):257-66. PubMed ID: 21540752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of head and neck melanoma.
    Schmalbach CE; Johnson TM; Bradford CR
    Curr Probl Surg; 2006 Nov; 43(11):781-835. PubMed ID: 17112819
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy of head and neck cancer.
    Castro JE
    Clin Otolaryngol Allied Sci; 1977 Feb; 2(1):65-75. PubMed ID: 338211
    [No Abstract]   [Full Text] [Related]  

  • 14. Report of a symposium on: diagnosis and treatment of cutaneous head and neck melanoma.
    Balm AJ; Kroon BB; de Boer JB; Israels SP; Jonk A; Mooi WJ; Neering H; Osterlind A; Rampen FH; Rankin EM
    Eur J Surg Oncol; 1994 Apr; 20(2):112-4. PubMed ID: 7910143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunocompetence and immunotherapy in patients with cancer of the head and neck region].
    Vinzenz K; Micksche M
    Z Stomatol; 1986 May; 83(3):203-18. PubMed ID: 3465128
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck.
    Suen JY; Richman SP; Livingston RB; Hersh EM; Craig R; Tonymon K
    Am J Surg; 1977 Oct; 134(4):474-8. PubMed ID: 911030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant melanoma in the area of the head and neck].
    Schwipper V
    Mund Kiefer Gesichtschir; 2000 May; 4 Suppl 1():S177-86. PubMed ID: 10938658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status and future perspective for immunotherapy in head and neck cancer patients].
    Okamoto Y
    Nihon Jibiinkoka Gakkai Kaiho; 2013 Feb; 116(2):118-9. PubMed ID: 24163852
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunotherapy for head and neck cancer].
    Chikamatsu K
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):802-5. PubMed ID: 26298887
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serological analysis of melanoma patients receiving autologous melanoma cell vaccines].
    Watanabe T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):261-72. PubMed ID: 6881976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.